Backed by Leaders, Protected Worldwide
Syntropic has earned the trust of leading investors and institutions, while safeguarding its technology through a strong and evolving global intellectual property portfolio.
Multi-Modal Innovation
Additional patent applications cover multiple stimulus modalities beyond light
Method-of-Use Protection
Strengthened US coverage through comprehensive method patents
Clinical Data Generation
Ongoing trials are generating new data leading to further IP filings
Strategic Focus
Ensuring broad, enforceable protection regardless of underlying mechanism